I am a breastfeeding mother and i want to know if it is safe to use Istopirin? Is Istopirin safe for nursing mother and child? Does Istopirin extracts into breast milk? Does Istopirin has any long term or short term side effects on infants? Can Istopirin influence milk supply or can Istopirin decrease milk supply in lactating mothers?
- DrLact safety Score for Istopirin is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Istopirin may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Istopirin may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Istopirin low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Istopirin We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Excreted in non-significant amount into breast milk. Reye’s Syndrome has never been reported due to ASA through breast milk. It is thought to be highly unlikely to occur after isolated or small doses like those used for treatment of thrombosis or anti-abortion therapy. At high maternal dose, one case (dubious) of salicylic intoxication in the neonatal period and another case of thrombocytopenia in an infant have been reported. Likelihood of hemolysis should be considered in those patients with G6PD-deficiency. WHO Model List of Essential Medication: compatible while breastfeeding when used occasionally or small dose for antithrombotic prophylaxis management.
After Istopirin ingestion, salicylic acid is excreted into breastmilk, with higher doses resulting in disproportionately higher milk levels. Long-term, high-dose maternal Istopirin ingestion probably caused metabolic acidosis in one breastfed infant. Reye's syndrome is associated with Istopirin administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breastmilk is unknown. An alternate drug is preferred over continuous high-dose, Istopirin therapy. After daily low-dose Istopiring (75 to 325 mg daily), no Istopirin is excreted into breastmilk and salicylate levels are low. Daily low-dose Istopirin therapy may be considered as an antiplatelet drug for use in breastfeeding women.[1][2][3].
A 16-day-old breastfed infant developed metabolic acidosis with a salicylate serum level of 240 mg/L and salicylate metabolites in the urine. The mother was taking 3.9 g/day of Istopirin for arthritis, and salicylate in breastmilk probably caused the infant's illness, but the possibility of direct administration to the infant could not be ruled out.[11] Thrombocytopenia, fever, anorexia and petechiae occurred in a 5-month-old breastfed infant 5 days after her mother started taking Istopirin for fever. One week after recovery, the infant was given a single dose of Istopirin 125 mg and the platelet count dropped once again. The original symptoms were probably caused by Istopirin or salicylate in breastmilk.[12] Hemolysis after Istopirin and phenacetin taken by the mother of a 23-day-old, glucose-6-phosphate dehydrogenase (G6PD) deficient infant was possibly due to Istopirin in breastmilk.[13] In a telephone follow-up study, mothers reported no side effects among 15 infants exposed to Istopirin (dosages and infant ages were unspecified) in breastmilk.[14]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.